Filing Details
- Accession Number:
- 0001645627-18-000082
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-12-31 13:39:17
- Reporting Period:
- 2018-12-21
- Accepted Time:
- 2018-12-31 13:39:17
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1528172 | Endonovo Therapeutics Inc. | ENDV | Pharmaceutical Preparations (2834) | 452552528 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1645627 | Scott Michael Mann | 6320 Canoga Avenue Woodland Hills CA 91367 | President | No | Yes | No | No |
Transaction Summary
| Purchased: | 83,199 shares | Avg. Price: $0.02 | Total Value: $1,739.44 |
| Number of Shares After Transactions: | 26,589,097 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-12-21 | 5,000 | $0.02 | 26,510,898 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-21 | 5,000 | $0.02 | 26,515,898 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-21 | 10,000 | $0.02 | 26,525,898 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-21 | 5,000 | $0.02 | 26,530,898 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-21 | 3,000 | $0.02 | 26,533,898 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-21 | 3,000 | $0.02 | 26,536,898 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-21 | 1,000 | $0.02 | 26,537,898 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-21 | 2,000 | $0.02 | 26,539,898 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-21 | 3,000 | $0.02 | 26,542,898 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-21 | 3,000 | $0.02 | 26,545,898 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-21 | 4,000 | $0.02 | 26,549,898 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-21 | 900 | $0.02 | 26,550,798 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-21 | 4,100 | $0.02 | 26,554,898 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-21 | 5,000 | $0.02 | 26,559,898 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-21 | 3,000 | $0.02 | 26,562,898 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-21 | 2,000 | $0.02 | 26,564,898 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-21 | 3,000 | $0.02 | 26,567,898 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-24 | 1,000 | $0.02 | 26,568,898 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-24 | 1,000 | $0.02 | 26,569,898 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-24 | 2,000 | $0.02 | 26,571,898 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-24 | 1,000 | $0.02 | 26,572,898 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-24 | 1,000 | $0.02 | 26,573,898 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-24 | 2,000 | $0.02 | 26,575,898 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-24 | 2,000 | $0.02 | 26,577,898 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-24 | 3,000 | $0.02 | 26,580,898 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-24 | 2,000 | $0.02 | 26,582,898 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-24 | 3,000 | $0.02 | 26,585,898 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-24 | 2,000 | $0.02 | 26,587,898 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-24 | 199 | $0.02 | 26,588,097 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-24 | 1,000 | $0.02 | 26,589,097 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Billionaire Hedge Funds
